LIXIGLAR Trademark

Trademark Overview

On Wednesday, July 8, 2015, a trademark application was filed for LIXIGLAR with the United States Patent and Trademark Office. The USPTO has given the LIXIGLAR trademark a serial number of 86686300. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 16, 2022. This trademark is owned by Sanofi. The LIXIGLAR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic preparations
lixiglar

General Information

Serial Number86686300
Word MarkLIXIGLAR
Filing DateWednesday, July 8, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 16, 2022
Registration Number4967773
Registration DateTuesday, May 31, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2016

Trademark Statements

Goods and ServicesAnti-diabetic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Friday, December 16, 2022CANCELLED SEC. 8 (6-YR)
Monday, May 31, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 31, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2016ASSIGNED TO LIE
Tuesday, January 19, 2016ASSIGNED TO LIE
Tuesday, January 5, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 9, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 9, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, September 9, 2015SUSPENSION LETTER WRITTEN
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Monday, July 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 11, 2015NEW APPLICATION ENTERED

Related Keywords

lixiglar preparations diabetic anti